Citadel Reports a 5.5% Stake in PTGX
January 4, 2023
Citadel Advisors LLC filed a 13G revealing an initial stake of 5.50% in Protagonist Therapeutics Inc $PTGX.
Here’s The Hot List, with data through January 3, 2023:
In another 13G, Suvretta Capital Management LLC reported a 7% stake in Terns Pharmaceuticals Inc $TERN.
In the options market, there was bullish flow in CSX Corporation $CSX, Cleveland-Cliffs Inc $CLF, Grab Holdings Limited $GRAB, and The Kraft Heinz Company $KHC.
Stay tuned. We'll be back on Thursday with more insider activity.
If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team